What is the treatment for hand, foot, and mouth disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hand, Foot, and Mouth Disease

Hand, foot, and mouth disease (HFMD) is a self-limiting viral illness that primarily requires supportive care focused on symptom relief, with no specific antiviral therapy recommended for routine cases.

Disease Overview

Hand, foot, and mouth disease is a highly contagious viral illness primarily affecting children under 10 years of age, though adults can also be affected. It is caused by various enteroviruses, most commonly:

  • Coxsackievirus A16
  • Enterovirus 71 (associated with more severe cases)
  • Coxsackievirus A6 (increasingly common in recent outbreaks)
  • Coxsackievirus A10

The disease is characterized by:

  • Low-grade fever
  • Painful oral ulcerations/enanthem
  • Maculopapular or papulovesicular rash on hands and feet
  • Typical incubation period of 3-10 days
  • Self-limiting course with resolution in 7-10 days

Treatment Approach

Supportive Care (First-Line Management)

  • Hydration: Ensure adequate fluid intake, especially important due to painful oral lesions that may limit intake 1
  • Pain management: Acetaminophen or ibuprofen as needed for pain and fever 1
  • Oral care: Soft, cold foods and beverages that don't irritate mouth ulcers

What to Avoid

  • Oral lidocaine is not recommended for pain management 1
  • Routine antibiotics are not indicated as this is a viral infection
  • No specific antiviral therapy is available or recommended for routine cases 2, 1

Special Considerations

Severe Cases

In rare instances, HFMD can lead to severe complications, particularly with EV71 infections:

  • Neurological complications (encephalitis, meningitis)
  • Cardiopulmonary complications (pulmonary edema)
  • Acute flaccid paralysis

For severe/complicated cases:

  • Intravenous immunoglobulin (IVIG) should be considered and has been recommended by several national guidelines 3, 4
  • Mechanical ventilation may be required for respiratory complications
  • Hospital admission for monitoring and supportive care

Atypical Presentations

  • Recent outbreaks caused by coxsackievirus A6 have shown more severe symptoms than "classical" HFMD 2
  • Onychomadesis (nail shedding) may occur 1-2 months after initial symptoms, particularly with coxsackievirus A6 infections 2

Prevention Measures

  • Handwashing is the most effective preventive measure 1
  • Surface disinfection of potentially contaminated surfaces and fomites 1
  • Avoid close contact with infected individuals
  • In high-risk areas, vaccination (available in mainland China against EV71) 5

Clinical Course and Follow-up

Most cases resolve completely within 7-10 days without specific treatment or sequelae 3. Patients and caregivers should be advised that:

  • The disease is highly contagious during the first week
  • Children should stay home from school/daycare until fever resolves and mouth sores heal
  • Hand hygiene is critical to prevent spread to other family members

Common Pitfalls to Avoid

  • Overtreatment with unnecessary antibiotics
  • Failure to ensure adequate hydration, especially in young children
  • Misdiagnosis - consider differential diagnoses including erythema multiforme, herpes, measles, and varicella 1
  • Failure to recognize severe cases requiring hospitalization (particularly EV71 infections)

By focusing on supportive care and symptom management, most cases of hand, foot, and mouth disease will resolve without complications.

References

Research

Hand-Foot-and-Mouth Disease: Rapid Evidence Review.

American family physician, 2019

Research

[Hand, foot and mouth disease--more than a harmless "childhood disease"].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Hand, Foot, and Mouth Disease: A Narrative Review.

Recent advances in inflammation & allergy drug discovery, 2022

Research

[Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease: a review].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2011

Research

Changing Epidemiology of Hand, Foot, and Mouth Disease Causative Agents and Contributing Factors.

The American journal of tropical medicine and hygiene, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.